These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 25948740

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
    Nishiyama S, Lokugamage N, Ikegami T.
    J Virol; 2016 Jan 27; 90(7):3735-44. PubMed ID: 26819307
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains.
    Alkan C, Jurado-Cobena E, Ikegami T.
    Viruses; 2024 Jun 21; 16(7):. PubMed ID: 39066162
    [Abstract] [Full Text] [Related]

  • 8. Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses.
    Nishiyama S, Ikegami T.
    Front Microbiol; 2015 Jun 21; 6():787. PubMed ID: 26322023
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.
    Kalveram B, Lihoradova O, Indran SV, Ikegami T.
    J Vis Exp; 2011 Nov 01; (57):e3400. PubMed ID: 22083261
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR, Johnston SC, Piper A, Botto M, Donnelly G, Shamblin J, Albariño CG, Hensley LE, Schmaljohn C, Nichol ST, Bird BH.
    PLoS Negl Trop Dis; 2018 May 01; 12(5):e0006474. PubMed ID: 29742102
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
    Nyundo S, Adamson E, Rowland J, Palermo PM, Matiko M, Bettinger GE, Wambura P, Morrill JC, Watts DM.
    Onderstepoort J Vet Res; 2019 Jan 31; 86(1):e1-e8. PubMed ID: 30843406
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
    Gowen BB, Bailey KW, Scharton D, Vest Z, Westover JB, Skirpstunas R, Ikegami T.
    Antiviral Res; 2013 May 31; 98(2):135-43. PubMed ID: 23523764
    [Abstract] [Full Text] [Related]

  • 18. Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.
    Lokugamage N, Ikegami T.
    NPJ Vaccines; 2017 May 31; 2():. PubMed ID: 29167748
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
    Wilson WC, Bawa B, Drolet BS, Lehiy C, Faburay B, Jasperson DC, Reister L, Gaudreault NN, Carlson J, Ma W, Morozov I, McVey DS, Richt JA.
    Vet Microbiol; 2014 Aug 06; 172(1-2):44-50. PubMed ID: 24856133
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.